Regeneron and Sanofi on Friday said the green light covers Dupixent as an add-on maintenance treatment in certain adults with uncontrolled chronic obstructive pulmonary disease, or COPD, and makes ...

Hudson Therapeutics, a leading innovator in therapeutic solutions and a US subsidiary of Shaperon, announced Shaperon’s entry ...

A new study reveals that infliximab, an anti-inflammatory drug, can improve motivation in patients with depression and high ...

A meta-analysis reveals triptans as the most effective acute migraine treatments, highlighting the need for their inclusion ...

A meta-analysis of 137 clinical trials finds triptan drugs are among the most effective for treating migraines, while newer ditan and gepant drugs were rated less highly ...

The effectiveness of new migraine treatments has been compared to paracetamol in a new study, which suggests drugs developed ...

New migraine drugs less effective than traditional painkillers, triptans, according to global analysis in The BMJ.

Camacho and colleagues’ study highlights the economic and health impacts of high risk non-steroidal anti-inflammatory drug ...

Pfizer’s cancer cachexia candidate has provided patients with clinically meaningful weight gain in a Phase II trial, with the ...

The article explores natural remedies for migraine relief through simple lifestyle changes. It presents seven warm blends ...